Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Document › Details

MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan.

Organisations Organisation MolMed S.p.A. (MLMD.MI)
  Group Asahi Glass (AGC) (Group)
  Organisation 2 Autolus Therapeutics Ltd.
  Today Autolus Therapeutics plc (Nasdaq: AUTL)
  Group Autolus Therapeutics plc (Nasdaq: AUTL)
Products Product contract manufacturing (biologicals)
  Product 2 Zalmoxis®
Persons Person Palmisano, Riccardo (MolMed 201606 CEO)
  Person 2 Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl)
     


   
Record changed: 2020-03-25

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Asahi Glass (AGC) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px




» top